Ocugen, Inc. announced that the U.S. FDA has granted Rare Pediatric Disease Designation to its treatment OCU410ST for ABCA4-associated retinopathies, including Stargardt disease. This follows prior ...
Scientists at the National Institutes of Health (NIH) have leveraged artificial intelligence to transform a device designed to see tissues in the back of the eye into one sharp enough to make out ...
Belite Bio, Inc., a clinical-stage biopharmaceutical company focusing on treatments for degenerative retinal diseases, announced that it will present two posters at the upcoming ARVO Annual Meeting ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. There were no serious adverse events reported in the six ...
SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today ...
USA, November 10, 2022 /EINPresswire.com/ -- Stargardt Disease (SGTD) is a hereditary retinal disease caused by mutations of the ABCA4 gene, impairing processing of ...
Detailed price information for Belite Bio Inc ADR (BLTE-Q) from The Globe and Mail including charting and trades.
7d
Cult band cancels UK tour after singer is diagnosed with health issue that could make him go blind
A CULT band has been forced to cancel their UK tour after one of the member’s revealed a devastating diagnosis. Popular indie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results